Search Results - "Hematologic malignancies"

Roche to Pay Nurix as Much as $2.3 Billion in Cancer Deal.

Authors: Kinzelmann, Fabienne (AUTHOR)

Source: Bloomberg.com. 6/8/2026, pN.PAG-N.PAG. 1p.

Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort Study.

Authors: Strongyli, Evlampia Papakonstantinou, Anna Demosthenous, Christos et al.

Source: Cancers. Jun2026, Vol. 18 Issue 11, p1803. 18p.

Molecular Insights and Novel Therapies for Lymphoproliferative Disorders.

Authors: Wan, Shucen Naik, Seema

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p5026. 22p.

Apigenin as a Multitarget Anticancer Agent: Coordinated Inhibition of EGFR/MAPK and PI3K/Akt Signaling in Hematologic Malignancies.

Authors: Terzi, Hatice Taştemur, Şeyma Öztürk, Ayşegül et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4657. 20p.

Radiogenomics in Lymphoma and Multiple Myeloma: A Systematic Review of Current Evidence and Future Directions.

Authors: Formica, Valentina Aghakhanyan, Gayane Baccolini, Valentina et al.

Source: Journal of Clinical Medicine. Jun2026, Vol. 15 Issue 11, p4048. 17p.

CHRONIC PRURITIS: UNMASKING A SINISTER DIAGNOSIS.

Authors: Teixeira, Miguel J. Thoresen, Jason

Source: Current Allergy & Clinical Immunology. Jun2026, Vol. 39 Issue 2, p118-121. 4p.

Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levels.

Authors: Hefner, Simon Stoffers, Philipp Langenberger, Benedikt et al.

Source: npj Biomedical Innovations. 6/2/2026, Vol. 3 Issue 1, p1-12. 12p.

The Hidden Biology of Life Experience: Using SEMOARS + GEM and Precision Health for Psychoneurologic Symptoms in Hematologic Malignancies.

Authors: Cazeau, Naomi^1,2 naomi.cazeau@vanderbilt.edu

Source: Clinical Journal of Oncology Nursing. Jun2026, Vol. 30 Issue 3, p242-247. 6p.

Prevalence and Molecular Characterization of Cryptosporidium Species in Patients With Hematologic Malignancies in Eastern Iran.

Authors: Solgi, Rahmat Mousavi, Seyed Mohammad Saeedi, Sadaf et al.

Source: International Journal of Microbiology. 5/25/2026, Vol. 2026, p1-7. 7p.

HLA‐G in Hematological Malignancies: Immunoregulatory Mechanisms and Implications for Immune Evasion and Immunotherapy.

Authors: Ribeiro, Thaís Lohana Chanel Pereira Nogueira, Glenda Menezes Souza-Barros, Mateus et al.

Source: Journal of Immunology Research. 5/4/2026, Vol. 2026, p1-12. 12p.

Targeting the WNT/β-Catenin Pathway in Hematological Malignancies: From Molecular Pathogenesis to Emerging Therapeutic Strategies.

Authors: Keyhani, Ali Haddad Kashani, Hamed Dizaji Asl, Khadijeh et al.

Source: Biomolecules (2218-273X). May2026, Vol. 16 Issue 5, p653. 22p.

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies.

Authors: Kemal, Chiara C. Zweers, Thijs J. Krekels, Elke H. J. et al.

Source: CPT: Pharmacometrics & Systems Pharmacology. May2026, Vol. 15 Issue 5, p1-12. 12p.

Immune interplay between sepsis and haematological malignancies.

Authors: Pons, Stéphanie Grosset, Morgane Touze, Emmanuelle et al.

Source: Intensive Care Medicine Experimental. 4/28/2026, Vol. 14 Issue 1, p1-10. 10p.

Cefiderocol in Children with Hematologic Malignancies—The Multicenter Retrospective Experience of the Infection Working Group of the Italian Pediatric Hematology and Oncology Association (AIEOP).

Authors: Muggeo, Paola Galaverna, Federica Chiusaroli, Lorenzo et al.

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 8, p3100. 15p.

Profiling Ten RHO GTPases in Myeloid Malignancies Reveals Distinct Expression Patterns and Prognostic Associations.

Authors: de Almeida Rodrigues, Beatriz de Paiva, Luciana Bueno Ramalho, Maria Carolina Clares et al.

Source: Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-8. 8p.

Patterns of thoracic involvement on MDCT in patients with hematological malignancies.

Authors: Hasan, Rana Mohsen Mohamed Osman, Ahmed M. Mohamed, Ahmed Mostafa et al.

Source: Egyptian Journal of Bronchology. 4/13/2026, Vol. 20 Issue 1, p1-9. 9p.

Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review.

Authors: Priessnitz, Jennifer Hariri, Ali Levkiavska, Yuliya et al.

Source: Case Reports in Hematology. 4/6/2026, Vol. 2026, p1-9. 9p.

The Incidence of Hemolytic and Serologic Transfusion Reactions Among Patients with Hematological Malignancies at Mbarara Regional Referral Hospital and the Uganda Cancer Institute, in Uganda.

Authors: Taremwa, Ivan Mugisha Niyonzima, Nixon Ashaba, Scholastic et al.

Source: Journal of Blood Medicine. Apr2026, Vol. 17, p1-14. 14p.

Integrating Artificial Intelligence, Circulating Tumor DNA, and Real-World Evidence to Optimize Hematologic Clinical Trials: Toward Adaptive and Learning Trial Designs.

Authors: Mahmoud, Abdurraouf Mokhtar Touti, Jasmitaben Prakashbhai Zaidi, Syed Rubina et al.

Source: Cancers. Apr2026, Vol. 18 Issue 7, p1173. 24p.

Prognostic Landscape of TP53 Mutations in Hematologic Malignancies.

Authors: Jang, Seo Yoon Jang, Joowon Lee, Jee-Soo et al.

Source: Cancer Research & Treatment. Apr2026, Vol. 58 Issue 2, p656-663. 8p.